Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinoma.
Meixia WangHanyao GuoBo ZhangYanan ShangSidi ZhangXiaoyu LiuPengxiu CaoYumei FanKe TanPublished in: Cancer cell international (2024)
A prognostic signature with 9 TFs performed well in predicting the survival rate and chemotherapy/immunotherapy effect of HCC patients. Trimetinib has potential application value in HCC by targeting TFs.